LAURA E FERGUSON-WEIGMAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care BEL AIR, MD NPI 1306244769
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care MD Acerta Pharma LLC All categories
General Payments — all program years on this page
$3,749.98
- Category: General Payments
- Program years: PY2022–2024
- Record count: 210
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,449.49 across 75 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,449.49 | 75 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $243.55 | 12 |
| Novo Nordisk AS | $187.19 | 10 |
| Amgen Inc. | $181.42 | 9 |
| ABBVIE INC. | $143.11 | 8 |
| GlaxoSmithKline, LLC. | $73.42 | 3 |
| OptiNose US, Inc. | $69.26 | 3 |
| Janssen Pharmaceuticals, Inc | $67.74 | 2 |
| Lilly USA, LLC | $62.64 | 4 |
| PFIZER INC. | $61.53 | 4 |
| DEXCOM, INC. | $40.72 | 2 |
| Lundbeck LLC | $35.35 | 2 |
| E.R. Squibb & Sons, L.L.C. | $34.34 | 2 |
| Merck Sharp & Dohme Corporation | $32.63 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $31.76 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.57 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.59 | 1 |
| Abbott Laboratories | $20.68 | 1 |
| Grifols USA, LLC | $19.82 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.37 | 1 |
| Corcept Therapeutics | $18.73 | 1 |
| HARMONY BIOSCIENCES LLC | $17.65 | 1 |
| Relypsa, Inc. | $14.53 | 1 |
| Esperion Therapeutics, Inc. | $14.51 | 1 |
| Exact Sciences Corporation | $14.38 | 1 |
By program year
Records — PY2024 (75)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.